Have a personal or library account? Click to login
Can MR Enterography and Diffusion-Weighted Imaging Predict Disease Activity Assessed by Simple Endoscopic Score for Crohn’s Disease? Cover

Can MR Enterography and Diffusion-Weighted Imaging Predict Disease Activity Assessed by Simple Endoscopic Score for Crohn’s Disease?

Journal of the Belgian Society of Radiology
Volume 103 (2019): Issue 1
By: Levent Soydan,  Ali Aslan Demir,  Serhat Ozer and  Selvinaz Ozkara  
Open Access
|Jan 2019

References

  1. 1Gucer, FI, Senturk, S, Ozkanli, S, Yilmabasar, MG, Koroglu, GA and Acar, M. Evaluation of Crohn’s disease activity by MR enterography: Derivation and histopathological comparison of an MR-based activity index. Eur J Radiol. 2015; 84(10): 1829–1834. DOI: 10.1016/j.ejrad.2015.06.005
    Back to article
  2. 2Li, XH, Sun, CH, Mao, R, et al. Assessment of Activity of Crohn’s Disease by Diffusion-Weighted Magnetic Resonance Imaging. Medicine (Baltimore). 2015; 94(43): e1819. DOI: 10.1097/MD.0000000000001819
    Back to article
  3. 3Buisson, A, Hordonneau, C, Goutte, M, Boyer, L, Pereira, B and Bommelaer, G. Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn’s disease. Aliment Pharmacol Ther. 2015; 42(4): 452–460. DOI: 10.1111/apt.13287
    Back to article
  4. 4Dohan, A, Taylor, S, Hoeffel, C, et al. Diffusion-weighted MRI in Crohn’s disease: Current status and recommendations. J Magn Reson Imaging. 2016, 44(6): 1381–1396. DOI: 10.1002/jmri.25325
    Back to article
  5. 5Moy, MP, Sauk, J and Gee, MS. The Role of MR Enterography in Assessing Crohn’s Disease Activity and Treatment Response. Gastroenterol Res Pract. 2016; 2016. DOI: 10.1155/2016/8168695
    Back to article
  6. 6Stanescu-Siegmund, N, Nimsch, Y, Wunderlich, AP, et al. Quantification of inflammatory activity in patients with Crohn’s disease using diffusion weighted imaging (DWI) in MR enteroclysis and MR enterography. Acta Radiol. 2017, 58(3): 264–271. DOI: 10.1177/0284185116648503
    Back to article
  7. 7Daperno, M, D’Haens, G, Van Assche, G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD. Gastrointest Endosc. 2004, 60(4): 505–512. DOI: 10.1016/S0016-5107(04)01878-4
    Back to article
  8. 8Sipponen, T, Nuutinen, H, Turunen, U and Farkkila, M. Endoscopic evaluation of Crohn’s disease activity: Comparison of the CDEIS and the SES-CD. Inflamm Bowel Dis. 2010, 16(12): 2131–2136. DOI: 10.1002/ibd.21300
    Back to article
  9. 9Khanna, R, Zou, G, Stitt, L, et al. Responsiveness of Endoscopic Indices of Disease Activity for Crohn’s Disease. Am J Gastroenterol. 2017, 112(10): 1584–1592. DOI: 10.1038/ajg.2016.580
    Back to article
  10. 10Maconi, G, Bolzoni, E, Giussani, A, Friedman, AB and Duca, P. Accuracy and cost of diagnostic strategies for patients with suspected Crohn’s disease. J Crohn’s Colitis. 2014, 8(12): 1684–92. DOI: 10.1016/j.crohns.2014.08.005
    Back to article
  11. 11Sinha, R, Murphy, P, Sanders, S, et al. Diagnostic accuracy of high-resolution MR enterography in Crohn’s disease: Comparison with surgical and pathological specimen. Clin Radiol. 2013, 68(9): 917–927. DOI: 10.1016/j.crad.2013.02.012
    Back to article
  12. 12Steward, MJ, Punwani, S, Proctor, I, et al. Non-perforating small bowel Crohn’s disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index. Eur J Radiol. 2012, 81(9): 2080–2088. DOI: 10.1016/j.ejrad.2011.07.013
    Back to article
  13. 13Rimola, J, Ordas, I, Rodriguez, S, et al. Magnetic resonance imaging for evaluation of Crohn’s disease: Validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis. 2011, 17(8): 1759–1768. DOI: 10.1002/ibd.21551
    Back to article
  14. 14Rimola, J, Rodriguez, S, Garcia-Bosch, O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009, 58(8): 1113–1120. DOI: 10.1136/gut.2008.167957
    Back to article
  15. 15Quaia, E, Cabibbo, B, Sozzi, M, et al. Biochemical markers and MR imaging findings as predictors of crohn’s disease activity in patients scanned by contrast-enhanced MR enterography. Acad Radiol. 2014, 21(10): 1225–1232. DOI: 10.1016/j.acra.2014.05.002
    Back to article
  16. 16Park, SH. DWI at MR Enterography for Evaluating Bowel Inflammation in Crohn’s Disease. AJR Am J Roentgenol. 2016, 207(1): 40–48. DOI: 10.2214/AJR.15.15862
    Back to article
  17. 17Pendse, DA, Makanyanga, JC, Plumb, AA, et al. Diffusion-weighted imaging for evaluating inflammatory activity in Crohn’s disease: Comparison with histopathology, conventional MRI activity scores, and faecal calprotectin. Abdom Radiol (NY). 2017, 42(1): 115–123. DOI: 10.1007/s00261-016-0863-z
    Back to article
  18. 18Tielbeek, JA, Ziech, ML, Li, Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014, 24(3): 619–629. DOI: 10.1007/s00330-013-3015-7
    Back to article
  19. 19Hordonneau, C, Buisson, A, Scanzi, J, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: Validation of quantitative index of activity. Am J Gastroenterol. 2014, 109(1): 89–98. DOI: 10.1038/ajg.2013.385
    Back to article
  20. 20Choi, SH, Kim, KW, Lee, JY, Kim, KJ and Park, SH. Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn’s Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2016, 22(3): 669–679. DOI: 10.1097/MIB.0000000000000607
    Back to article
  21. 21Kim, KJ, Lee, Y, Park, SH, et al. Diffusion-weighted MR enterography for evaluating Crohn’s disease: How does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis. 2015, 21(1): 101–109. DOI: 10.1097/MIB.0000000000000222
    Back to article
  22. 22Qi, F, Jun, S, Qi, QY, et al. Utility of the diffusion-weighted imaging for activity evaluation in Crohn’s disease patients underwent magnetic resonance enterography. BMC Gastroenterol. 2015; 15(12). DOI: 10.1186/s12876-015-0235-0
    Back to article
  23. 23Li, XH, Sun, CH, Mao, R, et al. Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn’s Disease: Results from an Observational Study. Inflamm Bowel Dis. 2017, 23(2): 244–253. DOI: 10.1097/MIB.0000000000001001
    Back to article
  24. 24Koutroumpakis, E and Katsanos, KH. Implementation of the simple endoscopic activity score in Crohn’s disease. Saudi J Gastroenterol. 2016, 22(3): 183–191. DOI: 10.4103/1319-3767.182455
    Back to article
  25. 25Quaia, E, Sozzi, M, Gennari, AG, Pontello, M, Angileri, R and Cova, MA. Impact of gadolinium-based contrast agent in the assessment of Crohn’s disease activity: Is contrast agent injection necessary? J Magn Reson Imaging. 2016, 43(3): 688–697. DOI: 10.1002/jmri.25024
    Back to article
  26. 26Rimola, J, Alvarez-Cofino, A, Perez-Jeldres, T, et al. Increasing efficiency of MRE for diagnosis of Crohn’s disease activity through proper sequence selection: A practical approach for clinical trials. Abdom Radiol (NY). 2017, 42(12): 2783–2791. DOI: 10.1007/s00261-017-1203-7
    Back to article
  27. 27Foti, PV, Farina, R, Coronella, M, et al. Crohn’s disease of the small bowel: Evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index. Radiol Med. 2015, 120(7): 585–594. DOI: 10.1007/s11547-015-0502-8
    Back to article
  28. 28Seo, N, Park, SH, Kim, KJ, et al. MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn’s Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study. Radiology. 2016, 278(3): 762–772. DOI: 10.1148/radiol.2015150809
    Back to article
  29. 29Oto, A, Kayhan, A, Williams, JT, et al. Active Crohn’s disease in the small bowel: Evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging. 2011, 33(3): 615–624. DOI: 10.1002/jmri.22435
    Back to article
  30. 30Buisson, A, Joubert, A, Montoriol, PF, et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther. 2013, 37(5): 537–545. DOI: 10.1111/apt.12201
    Back to article
  31. 31Ninivaggi, V, Missere, M, Restaino, G, et al. MR-enterography with diffusion weighted imaging: ADC values in normal and pathological bowel loops, a possible threshold ADC value to differentiate active from inactive Crohn’s disease. Eur Rev Med Pharmacol Sci. 2016, 20(21): 4540–4546.
    Back to article
  32. 32Kocaman, O. MR enterography: Still complementary to SES-CD for evaluation of ileal Crohn’s disease. Turk J Gastroenterol. 2014; 25(4): 458. DOI: 10.5152/tjg.2014.0023
    Back to article
  33. 33Buisson, A, Hordonneau, C, Goutte, M and Bommelaer, G. What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn’s Disease? Inflamm Bowel Dis. 2015; 21(6): E9. DOI: 10.1097/MIB.0000000000000415
    Back to article
DOI: https://doi.org/10.5334/jbsr.1521 | Journal eISSN: 2514-8281
Journal RSS Feed
Language: English
Submitted on: Feb 14, 2018
Accepted on: Dec 26, 2018
Published on: Jan 18, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Crohn’s Disease (CD),
MR Enterography,
Diffusion,
Disease Activity Score

© 2019 Levent Soydan, Ali Aslan Demir, Serhat Ozer, Selvinaz Ozkara, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 103 (2019): Issue 1Next article